Post-release opioid-related overdose mortality is the leading cause of death among people
released from jails or prisons (PRJP). Informed by the proximate determinants framework …

Polypharmacy is a growing problem and mechanisms of injury likely include potentially
inappropriate medications, total drug burden, known pairwise drug interactions, higher level …

Background and aims Despite the growing opioid overdose crisis, medication treatment for
opioid use disorder remains uncommon. The comparative effectiveness of buprenorphine …

Background Polypharmacy, defined as use of five or more medications concurrently, is
associated with adverse health outcomes and people ageing with HIV might be at greater …

Background Older people living with HIV (PLWH) are at increased risks of co-morbidities
and polypharmacy. However, little is known about factors affecting their needs and concerns …

Background: There has been a rising prevalence of polypharmacy among people living with
HIV (PLWH). Uncertainty however remains regarding the exact estimates of polypharmacy …

Background Given the increased attention to the opioid epidemic and the role of
inappropriate prescribing, there has been a marked increase in the number of studies using …

Background Chronic opioid therapy (COT) is common in people living with human
immunodeficiency virus (PLHIV), but is not well studied. We assessed opioid risk behaviors …

People living with HIV (PLWH) have high levels of functional impairment due to pain, also
called pain interference. Long-term opioid therapy (LTOT) is commonly prescribed for …

Among persons with HIV (PWH), unhealthy alcohol use and polypharmacy contribute to
bothersome symptoms (eg, fatigue, dizziness, memory loss). However, effective risk …